66 articles
The edge vascular response following implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold and the XIENCE V metallic everolimus-eluting stent. First serial follow-up assessment at six months and two years: insights from the first-in-man ABSORB Cohort B and SPIRIT II trials
- Gogas B,
- Bourantas C,
- Garcia-Garcia H,
- Onuma Y,
- Muramatsu T,
- Farooq V,
- Diletti R,
- van Geuns R-J,
- De Bruyne B,
- Chevalier B,
- Thuesen L,
- Smits P,
- Dudek D,
- Koolen J,
- Windecker S,
- Whitbourn R,
- McClean D,
- Dorange C,
- Miquel-Hebert K,
- Veldhof S,
- Rapoza R,
- Ormiston J,
- Serruys PW
EuroIntervention 2013; 8-online publish-ahead-of-print April 2013
Published ahead of print on April 30, 2013
The 2011-12 pilot European Sentinel Registry of Transcatheter Aortic Valve Implantation: in-hospital results in 4,571 patients
- Di Mario C,
- Eltchaninoff H,
- Moat N,
- Goicolea J,
- Ussia G,
- Kala P,
- Wenaweser P,
- Zembala M,
- Nickenig G,
- Barrero E,
- Snow T,
- Iung B,
- Zamorano P,
- Schuler G,
- Corti R,
- Alfieri O,
- Prendergast B,
- Ludman P,
- Windecker S,
- Sabate M,
- Gilard M,
- Witkowski A,
- Danenberg H,
- Schröder E,
- Romeo F,
- Macaya C,
- Derumeaux G,
- Maggioni A,
- Tavazzi L
EuroIntervention 2013;8:1362-1371
Published in Volume 8 Number 12, April 2013
Impact of atrial fibrillation on clinical outcomes among patients with coronary artery disease undergoing revascularisation with drug-eluting stents
- Pilgrim T,
- Kalesan B,
- Zanchin T,
- Pulver C,
- Jung S,
- Mattle H,
- Carrel T,
- Moschovitis A,
- Stortecky S,
- Wenaweser P,
- Stefanini GG,
- Räber L,
- Meier B,
- Jüni P,
- Windecker S
EuroIntervention 2013;8:1061-1071
Published in Volume 8 Number 9, January 2013
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document
- Kappetein AP,
- Head S,
- Généreux P,
- Piazza N,
- Van Mieghem N,
- Blackstone E,
- Brott T,
- Cohen D,
- Cutlip D,
- Van Es G-A,
- Hahn R,
- Kirtane A,
- Krucoff M,
- Kodali S,
- Mack M,
- Mehran R,
- Rodes-Cabau J,
- Vranckx P,
- Webb J,
- Windecker S,
- Serruys PW,
- Leon M
EuroIntervention 2012;8:782-795
Published in Volume 8 Number 7, November 2012
Transcatheter aortic valve implantation and cerebrovascular accidents
EuroIntervention 2012;8:Q60-Q69
Published in Volume 8 Supplement Q, September 2012
Welcome to PCR London Valves 2012
EuroIntervention 2012;8:Q7
Published in Volume 8 Supplement Q, September 2012
Head to head comparison of optical coherence tomography, intravascular ultrasound echogenicity and virtual histology for the detection of changes in polymeric struts over time: insights from the ABSORB trial
- Brugaletta S,
- Gomez-Lara J,
- Bruining N,
- Radu M,
- van Geuns R-J,
- Thuesen L,
- McClean D,
- Koolen J,
- Windecker S,
- Whitbourn R,
- Oberhauser J,
- Rapoza R,
- Ormiston J,
- García-García HM,
- Serruys PW
EuroIntervention 2012;8:352-358 published online ahead of print November 2011
Published in Volume 8 Number 3, July 2012
SPIRIT Women, evaluation of the safety and efficacy of the XIENCE V everolimus-eluting stent system in female patients: referral time for coronary intervention and 2-year clinical outcomes
- Morice M-C,
- Mikhail G,
- Mauri i Ferr F,
- Modena M,
- Strasser R,
- Grinfeld L,
- Sudhir K,
- Stuteville M,
- Papeleu P,
- Li D,
- Rutledge D,
- Windecker S
EuroIntervention 2012;8:325-335
Published in Volume 8 Number 3, July 2012
The SURTAVI model: proposal for a pragmatic risk stratification for patients with severe aortic stenosis
- Van Mieghem N,
- Head S,
- van der Boon R,
- Piazza N,
- de Jaegere P,
- Carrel T,
- Kappetein AP,
- Lange R,
- Walther T,
- Windecker S,
- Van Es G-A,
- Serruys PW
EuroIntervention 2012;8:258-266 publish online ahead of print March 2012
Published in Volume 8 Number 2, June 2012
Angiographic maximal luminal diameter and appropriate deployment of the everolimus-eluting bioresorbable vascular scaffold as assessed by optical coherence tomography: an ABSORB cohort B trial sub-study
- Gomez-Lara J,
- Diletti R,
- Brugaletta S,
- Onuma Y,
- Farooq V,
- Thuesen L,
- McClean D,
- Koolen J,
- Ormiston J,
- Windecker S,
- Whitbourn R,
- Dudek D,
- Dorange C,
- Veldhof S,
- Rapoza R,
- Regar E,
- García-García HM,
- Serruys PW
EuroIntervention 2012;8:214-224
Published in Volume 8 Number 2, June 2012
Cerebrovascular accidents complicating transcatheter aortic valve implantation: frequency, timing and impact on outcomes
- Stortecky S,
- Windecker S,
- Pilgrim T,
- Heg D,
- Buellesfeld L,
- Khattab A,
- Huber C,
- Gloekler S,
- Nietlispach F,
- Mattle H,
- Jüni P,
- Wenaweser P
EuroIntervention 2012;8:62-70
Published in Volume 8 Number 1, May 2012
Comparison of biolimus eluted from an erodible stent coating with bare metal stents in acute ST-elevation myocardial infarction (COMFORTABLE AMI trial): rationale and design
- Räber L,
- Kelbaek H,
- Ostoijc M,
- Baumbach A,
- Tüller D,
- von Birgelen C,
- Roffi M,
- Pedrazzini G,
- Kornowski R,
- Weber K,
- Heg D,
- Matter C,
- Lüscher T,
- Taniwaki M,
- Meier B,
- Jüni P,
- Windecker S
EuroIntervention 2012;7:1435-1443 publish online ahead of print February 2012
Published in Volume 7 Number 12, April 2012
The three year follow-up of the randomised “all-comers” trial of a biodegradable polymer biolimus-eluting stent versus permanent polymer sirolimus-eluting stent (LEADERS)
- Wykrzykowska J,
- Serruys PW,
- Buszman P,
- Linke A,
- Ischinger T,
- Klauss V,
- Eberli F,
- Corti R,
- Wijns W,
- Morice M-C,
- Di Mario C,
- van Geuns R-J,
- Van Es G-A,
- Jüni P,
- Windecker S
EuroIntervention 2011;7:789-795 publish online ahead of print October 2011
Published in Volume 7 Number 7, November 2011
Clinical outcomes after PCI for acute coronary syndrome in unprotected left main coronary artery disease: insights from the Swiss Acute Left Main Coronary Vessel Percutaneous Management (SALVage) study
- Puricel S,
- Adorjan P,
- Oberhänsli M,
- Stauffer J-C,
- Moschovitis A,
- Vogel R,
- Goy J-J,
- Muller O,
- Eeckhout E,
- Togni M,
- Wenaweser P,
- Meier B,
- Windecker S,
- Cook S
EuroIntervention 2011;7:697-704
Published in Volume 7 Number 6, October 2011
Implantation of the biodegradable polymer biolimus-eluting stent in patients with high SYNTAX score is associated with decreased cardiac mortality compared to a permanent polymer sirolimus-eluting stent: two year follow-up results from the “all-comers” LEADERS trial
- Wykrzykowska J,
- Garg S,
- Onuma Y,
- de Vries T,
- Morel M-A,
- Van Es G-A,
- Buszman P,
- Linke A,
- Ischinger T,
- Klauss V,
- Corti R,
- Eberli F,
- Wijns W,
- Morice M-C,
- Di Mario C,
- van Geuns R-J,
- Jüni P,
- Windecker S,
- Serruys PW
EuroIntervention 2011;7:605-613 publish online ahead of print June 2011
Published in Volume 7 Number 5, September 2011
Impact of coronary artery disease and percutaneous coronary intervention on outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation
- Wenaweser P,
- Pilgrim T,
- Guerios E,
- Stortecky S,
- Huber C,
- Khattab A,
- Kadner A,
- Buellesfeld L,
- Gloekler S,
- Meier B,
- Carrel T,
- Windecker S
EuroIntervention 2011;7:541-548
Published in Volume 7 Number 5, September 2011
Continuity and innovation: the yin and yang of interventional cardiology
EuroIntervention 2011;7:1-427
Published in Volume 7 Number 4, August 2011
Optical coherence tomography (OCT) of overlapping bioresorbable scaffolds: from benchwork to clinical application
- Farooq V,
- Onuma Y,
- Radu M,
- Okamura T,
- Gomez-Lara J,
- Brugaletta S,
- Gogas B,
- van Geuns R-J,
- Regar E,
- Schultz C,
- Windecker S,
- Lefèvre T,
- Brueren B,
- Powers J,
- Perkins L,
- Rapoza R,
- Virmani R,
- García-García HM,
- Serruys PW
EuroIntervention 2011;7:386-399 published online ahead of print January 2011
Published in Volume 7 Number 3, July 2011
The impact of coronary artery disease on clinical outcomes in patients undergoing TAVI
- Pilgrim T,
- Windecker S,
- Stortecky S,
- Huber C,
- Erdös G,
- Kadner A,
- Meuli F,
- Khattab A,
- Meier B,
- Carrel T,
- Wenaweser P
Published in Volume 7 Supplement M, May 2011
A six-month analysis of quantitative echogenicity of the second generation everolimus-eluting bioresorbable vascular scaffold in relationship with baseline greyscale intravascular ultrasound morphology of the scaffolded plaque
- Brugaletta S,
- Serruys PW,
- Ormiston J,
- Gomez-Lara J,
- Farooq V,
- van Geuns R-J,
- de Bruyne B,
- Dudek D,
- Thuesen L,
- Chevalier B,
- McClean D,
- Windecker S,
- Whitbourn R,
- Veldhof S,
- Miquel-Hebert K,
- Rapoza R,
- van Domburg R,
- Sihan K,
- de Winter S,
- García-García HM,
- Bruining N
Published in Volume 7 Supplement M, May 2011
Tissue coverage and neointimal hyperplasia of overlap vs. non-overlap segments in DES 9-13 months after implantation: in vivo-assessment with optical coherence tomography
- Gutiérrez-Chico J-L,
- Räber L,
- Regar E,
- Okamura T,
- Di Mario C,
- Windecker S,
- Valgimigli M,
- Sabate M,
- von Birgelen C,
- Van Es G-A,
- Serruys PW
Published in Volume 7 Supplement M, May 2011
Long-term tissue coverage of a bioresorbable polylactide polymer-coated Biolimus-eluting stent: comparative sequential assessment with optical coherence tomography till complete resorption of the polymer
- Gutiérrez-Chico J-L,
- Jüni P,
- García-García HM,
- Regar E,
- Borgia F,
- van der Giessen WJ,
- Davis S,
- van Geuns R-J,
- Secco G,
- Meis S,
- Windecker S,
- Serruys PW,
- Di Mario C
Published in Volume 7 Supplement M, May 2011
Tissue coverage of a hydrophilic polymer-coated Zotarolimus-eluting stent vs. a fluoropolymer-coated Everolimus-eluting stent at 13-month follow-up: an optical coherence tomography substudy from the RESOLUTE all-comers trial
- Gutiérrez-Chico J-L,
- van Geuns R-J,
- Regar E,
- van der Giessen WJ,
- Kelbæk H,
- Saunamäki K,
- Escaned-Barbosa J,
- Gonzalo N,
- Di Mario C,
- Borgia F,
- Nüesch E,
- García-García HM,
- Silber S,
- Windecker S,
- Serruys PW
Published in Volume 7 Supplement M, May 2011
Vascular healing response five years after implantation of first generation DES: the SIRTAX LATE optical coherence study
- Räber L,
- García-García HM,
- Baumgartner S,
- Kalesan B,
- Justiz J,
- Pilgrim T,
- Wenaweser P,
- Moschovitis A,
- Vogel R,
- Meier B,
- Jüni P,
- Serruys PW,
- Windecker S
Published in Volume 7 Supplement M, May 2011
Conformability of the Nevo; Sirolimus-eluting coronary stent system in comparison with the Xience; Everolimus-eluting coronary stent system: results from a bench top study and an angiographic assessment from the Nevo II clinical trial
- Gomez-Lara J,
- García-García HM,
- Windecker S,
- Sabate M,
- Pieters M,
- Jew V,
- Schroeder V,
- Grishaber R,
- Ryder K,
- Stoll H,
- Serruys PW
Published in Volume 7 Supplement M, May 2011
Angiographic geometric changes of the lumen vessel wall after bioresorbable vascular scaffolds and metallic platform stents at one-year follow-up
- Gomez-Lara J,
- Brugaletta S,
- Farooq V,
- van Geuns R-J,
- de Bruyne B,
- Windecker S,
- McClean D,
- Thuesen L,
- Dudek D,
- Koolen J,
- Whitbourn R,
- Smits P,
- Chevalier B,
- Morel M-A,
- Dorange C,
- Veldhof S,
- Rapoza R,
- García-García HM,
- Ormiston J
Published in Volume 7 Supplement M, May 2011
Pooled analysis of the Resolute programme clinical safety results
- Mauri L,
- Leon M,
- Yeung A,
- Meredith I,
- Serruys PW,
- Silber S,
- Belardi J,
- Neumann F-J,
- Widimsky P,
- Saito S,
- Massaro J,
- Fajadet J,
- Wijns W,
- Windecker S
Published in Volume 7 Supplement M, May 2011
Treatment with the Resolute Zotarolimus-eluting stent in subjects with diabetes mellitus: pooled analysis from the Resolute clinical programme
- Mauri L,
- Leon M,
- Yeung A,
- Meredith I,
- Serruys PW,
- Windecker S,
- Belardi J,
- Neumann F,
- Widimsky P,
- Saito S,
- Massaro J,
- Fajadet J,
- Wijns W,
- Silber S
Published in Volume 7 Supplement M, May 2011
The impact of anemia on long-term clinical outcome in patients undergoing PCI
- Pilgrim T,
- Vetterli F,
- Räber L,
- Binder R,
- Wenaweser P,
- Moschovitis A,
- Khattab A,
- Büllesfeld L,
- Vogel R,
- Seiler C,
- Meier B,
- Windecker S
Published in Volume 7 Supplement M, May 2011
e-BioMatrix PMS Registry - A post market surveillance registry for the BioMatrix™ drug-eluting stent
- Urban P,
- Al-Haddad I,
- Berland J,
- Eberli F,
- Fraser D,
- Goy J,
- Hildick - Smith D,
- Iosseliani D,
- Kleber F-X,
- Oldroyd K,
- Pedrazzini G,
- Roffi M,
- Valdes M,
- Windecker S,
- Jüni P
Published in Volume 7 Supplement M, May 2011
Comparison between the first and second generation bioresorbable vascular scaffolds: a six month virtual histology study
- Brugaletta S,
- García-García HM,
- Diletti R,
- Gomez-Lara J,
- Garg S,
- Onuma Y,
- Shin E,
- van Geuns R-J,
- de Bruyne B,
- Dudek D,
- Thuesen L,
- Chevalier B,
- McClean D,
- Windecker S,
- Whitbourn R,
- Dorange C,
- Veldhof S,
- Rapoza R,
- Sudhir K,
- Bruining N,
- Ormiston J,
- Serruys PW
EuroIntervention 2011;6:1110-1116
Published in Volume 6 Number 9, April 2011
The outcome of bifurcation lesion stenting using a biolimuseluting stent with a bio-degradable polymer compared to a sirolimus-eluting stent with a durable polymer
- Garg S,
- Wykrzykowska J,
- Serruys PW,
- de Vries T,
- Buszman P,
- Trznadel S,
- Linke A,
- Lenk K,
- Ischinger T,
- Klauss V,
- Eberli F,
- Corti R,
- Wijns W,
- Morice M-C,
- Di Mario C,
- Tyczynski P,
- van Geuns R-J,
- Eerdmans P,
- Van Es G-A,
- Meier B,
- Jüni P,
- Windecker S
EuroIntervention 2011;6:928-935
Published in Volume 6 Number 8, March 2011
Impact of arterial injury on neointimal hyperplasia after implantation of drug-eluting stents in coronary arteries: an intravascular ultrasound study
- Eshtehardi P,
- Cook S,
- Wandel S,
- Räber L,
- Wenaweser P,
- Togni M,
- Vogel R,
- Garachemani A,
- Eberli F,
- Lüscher T,
- Jüni P,
- Hess O,
- Meier B,
- Windecker S
EuroIntervention 2010;6:467-474 published online ahead of print June 2010
Published in Volume 6 Number 4, September 2010
The twelve-month outcomes of a biolimus eluting stent with a biodegradable polymer compared with a sirolimus eluting stent with a durable polymer
- Garg S,
- Sarno G,
- Serruys PW,
- de Vries T,
- Buszman P,
- Linke A,
- Ischinger T,
- Klauss V,
- Eberli F,
- Corti R,
- Wijns W,
- Morice M-C,
- Di Mario C,
- van Geuns R-J,
- Eerdmans P,
- Van Es G-A,
- Meier B,
- Jüni P,
- Windecker S
EuroIntervention 2010;6:233-239
Published in Volume 6 Number 2, June 2010
A randomised comparison of novolimus-eluting and zotarolimus-eluting coronary stents: 9-month follow-up results of the EXCELLA II study
- Serruys PW,
- Garg S,
- Abizaid A,
- Ormiston J,
- Windecker S,
- Verheye S,
- Dubois C,
- Stewart J,
- Hauptmann K,
- Schofer J,
- Stangl K,
- Witzenbichler B,
- Wiemer M,
- Barbato E,
- de Vries T,
- Drijver A-M,
- Otake H,
- Meredith L,
- Toyloy S,
- Fitzgerald P
EuroIntervention 2010;6:195-205
Published in Volume 6 Number 2, June 2010
Scientific societies and clinical trials
EuroIntervention 2010;6:185-188
Published in Volume 6 Number 2, June 2010
Randomised comparison of titanium-nitride-oxide coated stents with bare metal stents: five year follow-up of the TiNOX trial
- Moschovitis A,
- Simon R,
- Seidenstücker A,
- Klauss V,
- Baylacher M,
- RN R,
- Lüscher T,
- Moccetti T,
- Windecker S,
- Meier B,
- Hess O
EuroIntervention 2010;6:63-68
Published in Volume 6 Number 1, May 2010
Five-year outcome after implantation of sirolimus-eluting (SES) and paclitaxel-eluting (SES) stents in diabetic patients
- Räber L,
- Wenaweser P,
- Togni M,
- Cook S,
- Moschovitis A,
- Khattab A,
- Seiler C,
- Wandel S,
- Vogel R,
- Eberli F,
- Lüscher T,
- Meier B,
- Jüni P,
- Windecker S
Published in Volume 6 Supplement H, May 2010
Conformability of bioresorbable Everolimus-eluting scaffolds as compared to metal platform stents
- Gomez-Lara J,
- García-García HM,
- Onuma Y,
- Thuesen L,
- Dudek D,
- Garg S,
- de Bruyne B,
- Windecker S,
- Chevalier B,
- Smits P,
- McClean DR,
- Koolen J,
- Whitbourn R,
- Veldhof S,
- Dorange C,
- Ormiston J,
- Serruys PW
Published in Volume 6 Supplement H, May 2010
Malapposed struts in drug-eluting stents entail higher risk of incomplete tissue coverage at 9- to 13-month follow-up compared to well-apposed struts: in vivo demonstration with optical coherence tomography
- Gutiérrez-Chico J-L,
- Regar E,
- Jüni P,
- Okamura T,
- García-García HM,
- Van Es G-A,
- Kelbaek H,
- Macaya C,
- Silber S,
- Di Mario C,
- Windecker S,
- Serruys PW
Published in Volume 6 Supplement H, May 2010
Implications of floating struts at side branches in the tissue coverage of drug-eluting stents at 9- to 13-months follow-up: in vivo assessment with optical coherence tomography
- Gutiérrez-Chico J-L,
- Regar E,
- Jüni P,
- Okamura T,
- García-García HM,
- Van Es G-A,
- Kelbaek H,
- Macaya C,
- Silber S,
- Di Mario C,
- Windecker S,
- Serruys PW
Published in Volume 6 Supplement H, May 2010
Multicentre, prospective, randomised, single blind, consecutive enrollment evaluation of the Elixir Novolimus-eluting coronary stent system with durable polymer compared to the Endeavor Zotarolimus-eluting coronary stent system: 12-month clinical results and 9-month angiographic and IVUS results - the Excella II study
- Serruys PW,
- Garg S,
- Abizaid A,
- Ormiston J,
- Windecker S,
- Verheye S,
- Dubois C,
- Stewart J,
- Hauptmann K,
- Schofer J,
- Stangl K,
- Witzenbichler B,
- Wiemer M,
- Barbato E,
- de Vries T,
- Drijver A-M,
- Meredith L,
- Toyloy S,
- Otake H,
- Fitzgerald P
Published in Volume 6 Supplement H, May 2010
Vascular restoration therapy: what should the clinical and angiographic measures for success be?
EuroIntervention Supplement (2009) Vol. 5 (Supplement F) F49-F53
Published in Volume 5 Supplement F, December 2009
A comparison of patient characteristics and 30-day mortality outcomes after transcatheter aortic valve implantation and surgical aortic valve replacement for the treatment of aortic stenosis: a two-centre study
- Piazza N,
- van Gameren M,
- Jüni P,
- Wenaweser P,
- Carrel T,
- Onuma Y,
- Gahl B,
- Hellige G,
- Otten A,
- Kappetein AP,
- Takkenberg J,
- van Domburg R,
- de Jaegere P,
- Serruys PW,
- Windecker S
EuroIntervention 2009;5:580-588
Published in Volume 5 Number 5, November 2009
Biolimus-eluting biodegradable polymer versus sirolimuseluting permanent polymer stent performance in long lesions: results from the LEADERS multicentre trial substudy
- Wykrzykowska J,
- Räber L,
- Ton de Vries T,
- Bressers M,
- Buszman P,
- Linke A,
- Ischinger T,
- Klauss V,
- Eberli F,
- Corti R,
- Wijns W,
- Morice M-C,
- Di Mario C,
- Regar E,
- Jüni P,
- Windecker S,
- Serruys PW
EuroIntervention 2009;5:310-317
Published in Volume 5 Number 3, August 2009
The outcome of bifurcation lesion stenting using a biolimus eluting stent with a biodegradable polymer compared to a sirolimus eluting stent with a durable polymer
- Garg S,
- Wykrzykowska J,
- de Vries T,
- Simon W,
- Buszman P,
- Trznadel S,
- Linke A,
- Lenk K,
- Ischinger T,
- Klauss V,
- Eberli F,
- Conti R,
- Wijns W,
- Morice M-C,
- Di Mario C,
- Davis S,
- van Geuns R-J,
- Eerdmans P,
- Van Es G-A,
- Meier B,
- Jüni P,
- Windecker S,
- Serruys PW
Published in Volume 5 Supplement E, May 2009
A comparison of patient characteristics and 30-day mortality outcomes
after transcatheter aortic valve implantation and surgical aortic valve
replacement for the treatment of severe aortic stenosis: a two-center
propensity score analysis study
- Piazza N,
- van Gameren M,
- Wenaweser P,
- Carrel T,
- Onuma Y,
- Gahl B,
- Hellige D,
- Otten A,
- Kappetein AP,
- Jüni P,
- Takkenberg J,
- van Domburg R,
- de Jaegere P,
- Serruys PW,
- Windecker S
Published in Volume 5 Supplement E, May 2009
Meeting report. ESC Forum on Drug Eluting Stents, European Heart House, Nice, 27-28 September 2007
- Daemen J,
- Simoons M,
- Wijns W,
- Bagust A,
- Bos G,
- Bowen J,
- Braunwald E,
- Camenzind E,
- Chevalier B,
- Di Mario C,
- Fajadet J,
- Gitt A,
- Guagliumi G,
- Hillege H,
- James S,
- Jüni P,
- Kastrati A,
- Kloth S,
- Kristensen S,
- Krucoff M,
- Legrand V,
- Pfisterer M,
- Rothman M,
- Serruys PW,
- Silber S,
- Steg P,
- Tariah I,
- Wallentin L,
- Windecker S
EuroInterv.2009;4:427-436
Published in Volume 4 Number 4, January 2009
An introduction to "A critical appraisal of the safety concerns tempering the success of drug-eluting stents"
EuroIntervention Supplement (2008) Vol. 4 (Supplement C) C5-C6
Published in Volume 4 Supplement C, August 2008
Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) CoreValve ReValving System: results from the multicentre, expanded evaluation registry 1-year following CE mark approval
- Piazza N,
- Grube E,
- Gerckens U,
- den Heijer P,
- Linke A,
- Luha O,
- Ramondo A,
- Ussia G,
- Wenaweser P,
- Windecker S,
- Laborde J-C,
- de Jaegere P,
- Serruys PW
EuroInterv.2008;4:242-249
Published in Volume 4 Number 2, August 2008
Diabetic patients treated for unprotected left main coronary artery disease with drug eluting stents: a 3-year clinical outcome study. The Diabetes and Drug Eluting stent for LeFT main registry (D-DELFT)
- Meliga E,
- García-García HM,
- Valgimigli M,
- Chieffo A,
- Biondi-Zoccai G,
- O’ Maree A,
- Gonzalo N,
- Cook S,
- Cruz-Gonzalez I,
- Marra S,
- De Servi S,
- Palacios I,
- Windecker S,
- van Domburg R,
- Colombo A,
- Sheiban I,
- Serruys PW
EuroInterv.2008;4:77-83
Published in Volume 4 Number 1, May 2008
